Liposomal hyaluronic acid cosmetic composition with improved skin absorption comprising peptides
A nanoliposome formulation with specific peptides and hyaluronic acid addresses the low permeability issue, achieving high skin penetration and effective delivery for improved skin conditions.
Patent Information
- Application Number
- PCT/KR2026/005720
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-11-17
- Filing Date
- 2026-04-29
- Publication Date
- 2026-11-12
AI Technical Summary
Peptides and hyaluronic acid have low skin permeability, making it difficult to effectively deliver them to the deep layers of the skin, limiting their biological activities such as wrinkle improvement and skin regeneration.
Development of a nanoliposome formulation containing specific peptides (SEQ ID NO. 1 and SEQ ID NO. 2) and hyaluronic acid, with a multilayer lamellar structure, enhancing skin penetration efficiency while maintaining biological activity.
The nanoliposome achieves a high skin penetration rate with no irritation, significantly improving skin conditions through enhanced delivery of active ingredients, including skin moisturization, regeneration, and wrinkle reduction.
Smart Images

Figure KR2026005720_12112026_PF_FP_ABST
Abstract
Description
Hyaluronic acid liposome cosmetic composition containing peptides for enhanced skin absorption
[0001] The present invention relates to a nanoliposome comprising a peptide and a cargo.
[0002] With the advancement of modern dermatological science and drug delivery technology, technologies for effectively delivering various bioactive substances to the skin are gaining prominence. In particular, peptides are known as active ingredients exhibiting various biological activities such as wrinkle improvement, whitening, and skin regeneration, while hyaluronic acid is widely utilized in the cosmetics and pharmaceutical fields due to its excellent moisturizing properties and skin barrier strengthening effects. However, peptides and hyaluronic acid have limitations in that they have low skin permeability on their own, making it difficult to effectively deliver them to the deep layers of the skin. Accordingly, the development of delivery systems to stably and effectively deliver these ingredients to the skin has become an important technical challenge.
[0003] Liposomes are spherical vesicles with a phospholipid bilayer structure that offer the advantage of encapsulating and protecting various drugs or bioactive substances, thereby enhancing their delivery into the body or to the skin. In particular, nano-liposomes, which are liposomes with a size controlled to the nanometer (nm) level, are attracting attention in various fields recently due to their superior biocompatibility and stability, as well as their further improved skin permeability.
[0004] Therefore, there is an urgent need for the development of improved nano-liposome formulations that simultaneously contain peptides and cargo, such as hyaluronic acid, and can improve skin penetration efficiency while effectively maintaining their biological activity.
[0005] Accordingly, the inventors developed a nanoliposome containing peptides and cargo, and confirmed the skin penetration rate improvement and skin condition improvement effects, thereby completing the present invention.
[0006] Accordingly, the object of the present invention is to provide a nanoliposome comprising a peptide represented by the amino acid sequence of SEQ ID NO. 1; a peptide represented by the amino acid sequence of SEQ ID NO. 2; and a Cargo, and a method for manufacturing the same.
[0007] Another objective of the present invention is to provide a cosmetic composition for improving skin condition comprising the nanoliposomes.
[0008] Another objective of the present invention is to provide a cargo delivery composition comprising the nanoliposome.
[0009] Another objective of the present invention is to provide a method for manufacturing nanoliposomes comprising the steps of: (a) mixing a phospholipid, a peptide of SEQ ID NO. 1, and a peptide of SEQ ID NO. 2 to prepare a first mixture in which the peptides are dispersed; (b) mixing the first mixture of step (a) with a water-soluble cargo to prepare a second mixture; and (c) applying pressure to the second mixture of step (b) to nanoscale it.
[0010] Another objective of the present invention is to provide a method for improving skin condition comprising the step of administering a composition containing the nanoliposomes to an individual in need thereof.
[0011] Another objective of the present invention is to provide a cargo delivery method comprising the step of administering a composition containing the nanoliposomes to an individual in need thereof.
[0012] To achieve the above objective, the present invention provides a nanoliposome comprising: a peptide represented by the amino acid sequence of SEQ ID NO. 1; a peptide represented by the amino acid sequence of SEQ ID NO. 2; and a Cargo.
[0013] In addition, the present invention provides a cosmetic composition for improving skin condition comprising the above-mentioned nanoliposomes.
[0014] In addition, the present invention provides a cargo delivery composition comprising the above-mentioned nanoliposome.
[0015] In addition, the present invention provides a method for manufacturing a nanoliposome comprising: (a) mixing a phospholipid, a peptide of SEQ ID NO. 1, and a peptide of SEQ ID NO. 2 to prepare a first mixture in which the peptides are dispersed; (b) mixing the first mixture of step (a) and a water-soluble cargo to prepare a second mixture; and (c) applying pressure to the second mixture of step (b) to nanoscale it.
[0016] In addition, the present invention provides a method for improving skin condition comprising the step of administering a composition comprising a nanoliposome comprising a peptide represented by the amino acid sequence of SEQ ID NO. 1; a peptide represented by the amino acid sequence of SEQ ID NO. 2; and a Cargo to an individual in need thereof.
[0017] In addition, the present invention provides a method for delivering Cargo comprising the step of administering a composition comprising a nanoliposome comprising a peptide represented by the amino acid sequence of SEQ ID NO. 1; a peptide represented by the amino acid sequence of SEQ ID NO. 2; and Cargo to an individual in need thereof.
[0018] It was confirmed that the nanoliposome containing peptides and cargo according to the present invention has no skin irritation and a very high skin penetration rate. In addition, it was confirmed that the nanoliposome of the present invention has a significantly superior skin condition improvement effect compared to the control group. Therefore, the nanoliposome of the present invention can be utilized in various fields related to cargo delivery within the skin; and in fields related to skin condition improvement.
[0019] Figure 1 is a figure showing the structure of a nanoliposome according to the present invention.
[0020] Figure 2 is a figure showing the size measurement results of a nanoliposome according to the present invention.
[0021] Figure 3 is a figure showing the results of measuring skin irritation of nanoliposomes according to the present invention.
[0022] Figure 4 is a figure showing the results of measuring the skin penetration rate according to the nano liposome according to the present invention.
[0023] Figure 5 is a figure showing the results of measuring the expression of aquaporin-3, a moisturizing factor in the skin, according to the nano-liposome treatment of the present invention.
[0024] Figure 6 is a figure showing the results of measuring the expression of hyaluronic acid binding protein according to the nano-liposome treatment of the present invention.
[0025] Figure 7 is a figure showing the results of measuring the expression of Collagen-17:DEJ, a skin regeneration factor, according to the nano-liposome treatment of the present invention.
[0026] Figure 8 is a figure showing the results of measuring collagen activity in the skin according to the nano-liposome treatment of the present invention.
[0027] The present invention will be described in detail below.
[0028] According to an embodiment of the present invention, the present invention provides a nanoliposome comprising: a peptide represented by the amino acid sequence of SEQ ID NO. 1; a peptide represented by the amino acid sequence of SEQ ID NO. 2; and a carbone.
[0029] In the present invention, liposomes are small, spherical artificial vesicles in which phospholipids form a phospholipid bilayer, and are widely used in drug delivery systems. Since the liposomes can contain both hydrophilic and hydrophobic substances, they can efficiently deliver various drugs and nutrients.
[0030] In a specific embodiment of the present invention, it is preferable that one or more peptides selected from the group consisting of the peptide represented by the amino acid sequence of SEQ ID NO. 1 and the peptide represented by the amino acid sequence of SEQ ID NO. 2 are bound to the surface of a nanoliposome.
[0031] In a specific embodiment of the present invention, the cargo may be supported inside a nanoliposome.
[0032] In a specific embodiment of the present invention, the nanoliposome is a multilayer lamellar structure. More specifically, the nanoliposome of the present invention comprises: a first region formed by an internal hydrophilic region of the multilayer lamellar structure; a multilayer lamellar structure; and an external hydrophilic region of the multilayer lamellar structure.
[0033] In a preferred embodiment of the present invention, one or more peptides selected from the group consisting of a peptide represented by the amino acid sequence of SEQ ID NO. 1 and a peptide represented by the amino acid sequence of SEQ ID NO. 2 may be bonded to the outer hydrophilic region of the multilayer lamellar structure.
[0034] In a preferred embodiment of the present invention, the cargo may be included in a first region formed by an internal hydrophilic region of a multilayer lamellar structure, a multilayer lamellar structure, or an external hydrophilic region of a multilayer lamellar structure.
[0035] In the present invention, the multilayer lamellar structure is a structure formed by regularly stacking surfactants or lipids, and a particle comprising two or more double layers is referred to as a multilayer lamellar particle.
[0036] In a specific embodiment of the present invention, the cargo may be a hydrophilic cargo or a hydrophobic cargo. The hydrophilic cargo may be included in the first region or the outer hydrophilic region of the multilayer lamellar structure, and the hydrophobic cargo may be included in the multilayer lamellar structure.
[0037] Examples of the above hydrophilic carbohydrates include hyaluronic acid, ectoin, tranexamic acid, allantoin, caffeine, glutathione, niacinamide, lipoic acid, arbutin, adenosine, biotin, panthenol, ascorbic acid and its water-soluble derivatives, vitamin B groups, adenosine, glyceryl glucoside, xylityl glucoside, amino acids, carnitine, carnosine, crocin, and water-soluble natural extracts. It can be selected from the formed group.
[0038] In addition, the hydrophobic cargo may be a water-insoluble peptide, and more specifically, the water-insoluble peptide may be a peptide compound comprising a hydrophobic functional group such as a C6-C30 alkyl group, at least one or partially fluorinated C6-C30 alkyl group, an alkoxy group, an aryl group, a cholesteryl group, an aromatic group, and preferably, it may be selected from the group consisting of Palmitoyl Pentapeptide-4, Palmitoyl Tetrapeptide-7, Palmitoyl Tripeptide-5, Palmitoyl Tripeptide-1, Acetyl Hexapeptide-38, and Biotinoyl Tripeptide-1.
[0039] In a preferred embodiment of the present invention, the cargo is preferably of a size that can be supported on a nano-sized nanoliposome of the present invention, and may be, for example, hyaluronic acid having a molecular weight of 3,000 to 3,000,000 Da, preferably hyaluronic acid having a molecular weight of 10,000 to 1,500,000 Da, and more preferably hyaluronic acid having a molecular weight of 100,000 to 1,000,000 Da, but the scope of the present invention is not limited thereto. In addition, the hyaluronic acid may have a nano-size, which may be 0.1 to 10 nm, preferably 0.5 to 8 nm.
[0040] Preferably, the nanoliposome of the present invention may comprise 0.001-5% hyaluronic acid; 0.000001-1% by weight of a peptide represented by the amino acid sequence of SEQ ID NO. 1; and 0.0001-5% by weight of a peptide represented by the amino acid sequence of SEQ ID NO. 2. Preferably, the nanoliposome may comprise 0.01-0.5% by weight hyaluronic acid; 0.00001-0.01% by weight of a peptide represented by the amino acid sequence of SEQ ID NO. 1; and 0.01-0.5% by weight of a peptide represented by the amino acid sequence of SEQ ID NO. 2, but the scope of the present invention is not limited thereto.
[0041] In a specific embodiment of the present invention, the nanoliposome is preferably 1 to 500 nm in size, more preferably 10 to 100 nm, and most preferably has an average particle size of 54 nm.
[0042] In a specific embodiment of the present invention, the nanoliposome may be for transdermal administration. In an embodiment of the present invention, it was experimentally confirmed that the skin penetration rate of the nanoliposome of the present invention increased by 2.6 to 18 times compared to the control group.
[0043] In summary, the nanoliposome of the present invention has a structure as shown in FIG. 1. Specifically, the nanoliposome has (i) the peptide of SEQ ID NO. 1 and the peptide of SEQ ID NO. 2 bound to its surface, and (ii) a cargo loaded inside. In the embodiments of the present invention, it was confirmed that the nanoliposome of the present invention can effectively deliver useful substances contained within it to the skin, as it causes no skin irritation and has a very high skin penetration rate. Furthermore, it was confirmed that the nanoliposome of the present invention has a significantly superior effect on improving skin condition (i.e., skin moisturization, skin regeneration, and wrinkle improvement) compared to the control group. Therefore, the nanoliposome of the present invention can be utilized in various fields related to cargo delivery within the skin and in fields related to improving skin condition.
[0044]
[0045] According to another aspect of the present invention, the present invention provides a cosmetic composition for improving skin condition comprising the nanoliposome.
[0046] In a specific embodiment of the present invention, the improvement of the skin condition may be skin moisturization, skin regeneration, improvement of skin wrinkles, enhancement of skin elasticity, alleviation of skin irritation, or skin soothing.
[0047] In an embodiment of the present invention, it was confirmed that the nanoliposomes of the present invention not only cause no skin irritation but also have a significantly higher skin penetration rate compared to the control group. Furthermore, it was confirmed that the nanoliposomes significantly increase the expression of moisturization-related factors (aquaporin-3, hyaluronic acid binding protein) and skin regeneration-related factors Collagen-17:DEJ, and significantly increase collagen involved in skin wrinkles. Therefore, the nanoliposomes of the present invention can be usefully utilized in the field of cosmetics for skin soothing, skin moisturization, skin regeneration, and improvement of wrinkle-related symptoms.
[0048] When the nano liposome according to the present invention is used as a cosmetic, in addition to the compound, it may include conventional cosmetic base ingredients, such as conventional emulsifiers like stabilizers, solubilizers, pigments, and fragrances, and a carrier. Furthermore, it may be manufactured in any formulation conventionally produced in the cosmetic industry, and although not specifically limited, it may have a formulation such as a lotion, essence, lotion, paste, surfactant-containing cleansing product, cream, pack, gel, ointment, powder, patch, or spray.
[0049] In the case where the formulation of the above cosmetic composition is a paste, cream, or gel, one or more selected from the group consisting of animal oil, vegetable oil, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, and zinc oxide may be used as carrier components, and in the case where the formulation is a lotion or essence, a solvent, a solubilizing agent, or an emulsifying agent may be used as carrier components, for example, one or more selected from the group consisting of water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylene glycol, oil, glycerol aliphatic ester, polyethylene glycol, and fatty acid ester of sorbitan may be used.
[0050] In addition, if the formulation of the cosmetic composition is a powder or a spray, one or more selected from the group consisting of lactose, talc, silica, aluminum hydroxide, calcium silicate, and polyamide powder may be used as carrier components, and in particular, if it is a spray, it may additionally include a propellant such as chlorofluorohydrocarbon, propane / butane, or dimethyl ether. In addition, if the formulation of the cosmetic composition is a surfactant-containing cleansing agent, one or more selected from the group consisting of aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide ether sulfate, alkylamidobetaine, aliphatic alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative, and ethoxylated glycerol fatty acid ester may be used as carrier components.
[0051] At this time, the nano liposomes in the cosmetic product are preferably added in an amount of 0.001 to 50% by weight of the total weight, preferably 0.01 to 30% by weight.
[0052]
[0053] According to another aspect of the present invention, the present invention provides a cargo delivery composition comprising the nanoliposome.
[0054] To achieve the material transfer purpose of the present invention, a Cargo may be further included inside or outside the nanoliposome. For example, the Cargo may be an active ingredient having a skin condition improving effect, may be selected from the aforementioned water-soluble Cargo or hydrophobic Cargo, and may be delivered by being included in a first region formed by an internal hydrophilic region of a multilayer lamellar structure, a multilayer lamellar structure, or an external hydrophilic region of a multilayer lamellar structure. In this case, preferably, delivery may be made via transdermal administration.
[0055]
[0056] According to another aspect of the present invention, the present invention provides a method for manufacturing the nano liposome. The method for manufacturing the nano liposome of the present invention comprises: (a) mixing a phospholipid, a peptide of SEQ ID NO. 1, and a peptide of SEQ ID NO. 2 to prepare a first mixture in which the peptides are dispersed; (b) mixing the first mixture of step (a) and a water-soluble cargo to prepare a second mixture; and (c) applying pressure to the second mixture of step (b) to nano-size it.
[0057] In a specific embodiment of the present invention, the phospholipid is phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI), phosphatidylglycerol (PG), sphingomyelin, lecithin, hydrogenated lecithin, dipalmitoylphosphatidylcholine (DPPC), distearoylphosphatidylcholine (DSPC), dioleoylphosphatidylcholine (DOPC), dioleoylphosphatidylethanolamine, It may be DOPE), distearoylphosphatidylethanolamine (DSPE), distearoylphosphatidylethanolamine-PEG2000 (DSPE-PEG2000), 1,2-dioreoyl-3-trimethylammoniumpropane (DOTAP), cholesterol, ceramide NP, or hydrogenated polydecene, and in the embodiments of the present invention, hydrogenated polydecene was used.
[0058] In a specific embodiment of the present invention, step (c) may involve nano-sizing a second mixture in a liquid phase by applying a pressure of 10,000 to 50,000 psi. Additionally, after performing step (c), a step of cooling for 1 to 10 hours under conditions of -10 to 50°C may be additionally performed.
[0059] The nanoliposomes produced by the method of the present invention preferably have a size of 1 to 500 nm, more preferably 10 to 100 nm, and most preferably an average particle size of 54 nm.
[0060]
[0061] According to another aspect of the present invention, a method for improving skin condition is provided, comprising the step of administering a composition comprising a nanoliposome comprising a peptide represented by the amino acid sequence of SEQ ID NO. 1; a peptide represented by the amino acid sequence of SEQ ID NO. 2; and a Cargo to an individual in need thereof.
[0062] In a specific embodiment of the present invention, the improvement of the skin condition may be skin moisturization, skin regeneration, improvement of skin wrinkles, enhancement of skin elasticity, alleviation of skin irritation, or skin soothing.
[0063] In a specific embodiment of the present invention, the individual may be an individual expected to require skin improvement, specifically an individual requiring effects such as skin moisturization, whitening, wrinkle improvement, skin regeneration, antioxidant or skin barrier improvement, but is not limited thereto.
[0064] In a specific embodiment of the present invention, the composition may be in the form of a cosmetic composition, a quasi-drug composition, or a pharmaceutical composition, but is not limited thereto. The cosmetic composition may be provided in various formulations such as skin, toner, essence, serum, ampoule, lotion, cream, gel, oil, mist, patch, or mask pack, and may additionally include emulsifiers, moisturizers, thickeners, stabilizers, antioxidants, fragrances, colorants, and preservatives used in conventional cosmetic compositions. The quasi-drug composition may be provided in external formulations such as ointments, creams, gels, lotions, sprays, or patches for skin protection or improvement. The pharmaceutical composition may include a pharmaceutically acceptable carrier, and the carrier may include physiological saline, a buffer solution, a solvent, a dispersant, or a stabilizer. The pharmaceutical composition may be applied in a parenteral form including external application to the skin, but is not limited thereto.
[0065] In a specific embodiment of the present invention, the composition is a composition for transdermal administration, and by applying it directly to the skin or in the form of a patch, the active ingredient is effectively delivered through the skin, thereby providing an effect of improving the skin condition.
[0066]
[0067] According to another aspect of the present invention, a method for delivering Cargo is provided, comprising the step of administering a composition comprising a nanoliposome comprising a peptide represented by the amino acid sequence of SEQ ID NO. 1; a peptide represented by the amino acid sequence of SEQ ID NO. 2; and Cargo to an individual in need thereof.
[0068] In a specific embodiment of the present invention, the individual may be an individual requiring the delivery of the cargo, and more specifically, may be an individual requiring effects such as skin moisturization, whitening, wrinkle improvement, skin regeneration, antioxidant or skin barrier improvement, but is not limited thereto.
[0069] The above-mentioned subject may be a subject requiring improvement of skin conditions such as, for example, skin dryness, pigmentation, skin aging, decreased skin elasticity, skin irritation, or damage, and the physiological activity of said cargo can be efficiently exerted by effectively delivering hydrophilic or hydrophobic cargo to such subject through the nanoliposome of the present invention.
[0070] In particular, hydrophilic cargoes such as hyaluronic acid, niacinamide, glutathione, panthenol, ascorbic acid, or B vitamins, or hydrophobic cargoes such as palmitoyl pentapeptide-4, palmitoyl tripeptide-1, or acetyl hexapeptide-38, may have limited skin delivery efficiency, but transdermal delivery efficiency can be improved by using the nanoliposomes of the present invention.
[0071]
[0072] Redundant content is omitted out of consideration for the complexity of this specification, and terms not otherwise defined in this specification have the meanings commonly used in the technical field to which this invention belongs.
[0073] The present invention will be described in more detail below through examples. These examples are solely for illustrating the present invention, and it will be obvious to those skilled in the art that the scope of the present invention is not to be interpreted as being limited by these examples.
[0074]
[0075] Example 1: Preparation of Nanoliposomes
[0076] In this embodiment, a nanoliposome was prepared. The nanoliposome of the present invention is characterized by (i) the peptide of SEQ ID NO. 1 and the peptide of SEQ ID NO. 2 being bound to the surface of the nanoliposome, and (ii) hyaluronic acid being loaded inside. A schematic diagram of the nanoliposome of the present invention is shown in FIG. 1.
[0077] First, to prepare nanoliposomes, the peptides in Table 1 below were obtained by a solid-phase synthesis method using Fmoc(9-luorenylmethoxycarbonyl) as a protecting group for Nα-amino acids.
[0078] Sequence Number Name Sequence 1 Arginine / Lysine Polypeptide (Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg 2 Carnosine (Ala-His(Ala: Beta-alanine))
[0079] The peptide of SEQ ID NO. 1, the peptide of SEQ ID NO. 2, and hyaluronic acid (molecular weight 3,000 to 3,000,000 Da or less) were sequentially introduced into the following manufacturing processes (a) to (f) to produce nanoliposomes using ultrasonic dispersion and heating / pressurization methods.
[0080]
[0081] (a) A step of heating solid hydrogenated polydecene to liquefy it.
[0082] - Using PHCbi, MIR-H263 model
[0083] - Treat at a temperature of 30 to 80°C for 2 to 24 hours
[0084] - A hydrogenated polydecene mixture was prepared by adding purified water, glycerin, 1,2-hexanediol, isoamyl laurate, polyglyceryl-3-methylglucose distearate, butylene glycol, methylglucose sesquistearate, and cetearyl glucoside to solid hydrogenated polydecene and then heating and stirring to liquefy it.
[0085]
[0086] (b) loading the peptide of SEQ ID NO. 1 and the peptide of SEQ ID NO. 2 into a liquid hydrogenated polydecene mixture
[0087] - SONICS & MATERIALS, using VCX 750 model
[0088] - Process for 15–120 minutes at a value of 130–750 Watts
[0089] - Ultrasound was applied to the hydrogenated polydecene mixture prepared in step (a) above to evenly disperse the loaded peptide of SEQ ID NO. 1 and peptide of SEQ ID NO. 2.
[0090]
[0091] (c) A step of cooling and stabilizing a liquid hydrogenated polydecene mixture in which two types of peptides are evenly dispersed.
[0092] - LAUDA uses Eco model
[0093] - -50~15℃, treatment for 1~6 hours
[0094] - A hydrogenated polydecene mixture in which two types of peptides were evenly dispersed was stabilized by cooling.
[0095]
[0096] (d) a step of heating to solubilize a hydrogenated polydecene mixture containing two types of peptides; and a hyaluronic acid solution.
[0097] - Cbi, using the MIR-H263 model
[0098] - Treat at a temperature of ~80℃ for 2 to 24 hours
[0099] - A hyaluronic acid solution was prepared by adding water to hyaluronic acid and heating it. The prepared hyaluronic acid solution and the hydrogenated polydecene mixture prepared in step (c) were mixed and stirred to obtain a hydrogenated polydecene liquid phase.
[0100]
[0101] (e) A step of nano-sizing a hydrogenated polydecene liquid phase to which hyaluronic acid (0.0750 wt%), the peptide of SEQ ID NO. 1 (0.00025 wt%), and the peptide of SEQ ID NO. 2 (0.12475 wt%) are applied by applying pressure.
[0102] - Microfluidics, using the LM20 model
[0103] - Use 20,000 ~ 30,000 psi
[0104] - The hydrogenated polydecene liquid phase of step (d) above was nanosized by applying pressure.
[0105]
[0106] (f) Step of cooling and stabilizing the liquid phase of hydrogenated polydecene
[0107] - LAUDA uses Eco model
[0108] - -50~15℃, treatment for 1~6 hours
[0109] - The nano-sized composition obtained in step (e) above was stabilized by cooling. The stabilized composition contains nano-liposomes.
[0110]
[0111] The synthesized nanoliposomes were named 'T-Solution Hydra Factor'.
[0112]
[0113] Example 2: Particle Size Analysis of Nanoliposomes
[0114] The nano-sized composition prepared in Example 1 above contains the nano-liposomes of the present invention. The size of the prepared nano-liposomes was measured, and the results are shown in Figure 2.
[0115] As shown in Figure 2, it was confirmed that the nanoliposome prepared in Example 1 had an average particle size of 54 nm.
[0116]
[0117] Example 3: Measurement of skin irritation by Nino Liposomes
[0118] A patch containing the manufactured nanoliposomes was applied to the back (excluding the spine) for 24 hours. Skin irritation was first assessed 30 minutes after patch removal and secondly assessed 24 hours after patch removal. The final level of skin irritation was determined based on the results of the first and second assessments. The results of measuring skin irritation by the nanoliposomes are shown in Figure 3.
[0119] As shown in Figure 3, the skin irritation of the nano liposome (T-Solution Hydra Factor) of the present invention was measured, and the skin reactivity was found to be 0 for up to 24 hours in all experimental groups, so it was determined to be 'non-irritating' with no skin irritation.
[0120]
[0121] Example 4: Measurement of skin penetration rate of nanoliposomes
[0122] The nano-sized composition prepared in Example 1 above contains the nano-liposomes of the present invention. The skin penetration rate of the prepared nano-liposomes was measured. Specifically, the skin penetration rate was measured using human skin tissue, and an experimental group was designed as follows.
[0123] - Normal: Formulation without added sample
[0124] - Sodium Hyaluronate: Sodium Hyaluronate-added formulation
[0125] - Nano-HA: Sodium Hyaluronate Nano-liposome Added Formulation
[0126] - T-Solution Hydra Factor: Nano-liposome-added formulation of the present invention
[0127] The skin penetration rate was compared to the improvement in penetration rate compared to the group without added samples. The results of observing skin penetration in 2D and 3D are shown in Figure 4.
[0128] As shown in Figure 4, it was confirmed that the control groups, Sodium Hyaluronate and Nano-HA, had skin penetration rates of 12% and 82%, respectively. On the other hand, the skin penetration rate of the nano-liposome of the present invention was 215%, confirming that the skin penetration rate was significantly higher than that of the control group.
[0129]
[0130] Example 5: Measurement of skin moisturizing efficacy of nanoliposomes
[0131] The nano-sized composition prepared in Example 1 above contains the nano-liposomes of the present invention. The skin moisturizing efficacy of the prepared nano-liposomes was measured. Specifically, the skin moisturizing efficacy was measured using human skin tissue, and an experimental group was designed as follows.
[0132] - Normal: Formulation without added sample
[0133] - Sodium Hyaluronate: Sodium Hyaluronate-added formulation
[0134] - Nano-HA: Sodium Hyaluronate Nano-liposome Added Formulation
[0135] - T-Solution Hydra Factor: Nano-liposome-added formulation of the present invention
[0136] Skin moisturizing efficacy was analyzed by examining the expression of aquaporin-3 and hyaluronic acid binding protein. The results of confirming changes in the expression of proteins related to moisturizing efficacy are shown in Figures 5 and 6, respectively.
[0137] As shown in Figure 5, it was confirmed that the expression of aquaporin-3, a skin moisturizing protein, increased by 20% and 68%, respectively, in the control group Sodium Hyaluronate and Nano-HA. The nano-liposome of the present invention showed a 157% increase in the expression of aquaporin-3, which means that the skin moisturizing efficacy is significantly higher than that of the control group.
[0138] As shown in Figure 6, it was confirmed that the expression of hyaluronic acid binding protein, a skin moisturizing protein, increased by 18% and 26%, respectively, in the control group Sodium Hyaluronate and Nano-HA. The nano-liposome of the present invention showed an 87% increase in the expression of hyaluronic acid binding protein, which means that the skin moisturizing efficacy is significantly higher than that of the control group.
[0139]
[0140] Example 6: Measurement of Skin Regeneration Efficacy of Nanoliposomes
[0141] The nano-sized composition prepared in Example 1 above contains the nano-liposomes of the present invention. The skin regeneration efficacy of the prepared nano-liposomes was measured. Specifically, the skin regeneration efficacy was measured using human skin tissue, and an experimental group was designed as follows.
[0142] - Normal: Formulation without added sample
[0143] - Sodium Hyaluronate: Sodium Hyaluronate-added formulation
[0144] - Nano-HA: Sodium Hyaluronate Nano-liposome Added Formulation
[0145] - T-Solution Hydra Factor: Nano-liposome-added formulation of the present invention
[0146] The skin regeneration efficacy was confirmed by analyzing the expression of Collagen-17:DEJ (Collagen-17: dermo-epidermal junction). The results of confirming changes in the expression of proteins related to skin regeneration efficacy are shown in Figure 7.
[0147] As shown in Figure 7, it was confirmed that the control group, Sodium Hyaluronate, and Nano-HA, showed an increase in Collagen-17:DEJ of 8% and 62%, respectively. The nano-liposome of the present invention showed an increase in Collagen-17:DEJ of 285%, which means that the skin regeneration efficacy is significantly higher compared to the control group.
[0148]
[0149] Example 7: Measurement of the skin wrinkle improvement efficacy of nanoliposomes
[0150] The nano-sized composition prepared in Example 1 above contains the nano-liposomes of the present invention. The skin wrinkle improvement efficacy of the prepared nano-liposomes was measured. Specifically, the skin wrinkle improvement efficacy was measured using human skin tissue, and an experimental group was designed as follows.
[0151] - Normal: Formulation without added sample
[0152] - Sodium Hyaluronate: Sodium Hyaluronate-added formulation
[0153] - Nano-HA: Sodium Hyaluronate Nano-liposome Added Formulation
[0154] - T-Solution Hydra Factor: Nano-liposome-added formulation of the present invention
[0155] The efficacy of improving skin wrinkles was confirmed by analyzing the expression of collagen. The results of confirming changes in the expression of proteins related to the efficacy of improving skin wrinkles are shown in Figure 8.
[0156] As shown in Figure 8, it was confirmed that the control groups, Sodium Hyaluronate and Nano-HA, showed an increase in collagen of 79% and 81%, respectively. The nano-liposome of the present invention showed an increase in collagen of 385%, which means that the skin wrinkle improvement efficacy is significantly higher compared to the control group.
[0157]
[0158] In summary, the inventors prepared a nanoliposome as shown in FIG. 1. The nanoliposome of the present invention is characterized by (i) having the peptide of SEQ ID NO. 1 and the peptide of SEQ ID NO. 2 bound to its surface, and (ii) having hyaluronic acid loaded inside. It was confirmed that the nanoliposome of the present invention causes no skin irritation and has a very high skin penetration rate. Furthermore, it was confirmed that the nanoliposome of the present invention has a significantly superior skin condition improvement effect (i.e., skin moisturization, skin regeneration, and wrinkle improvement) compared to the control group. Therefore, the nanoliposome of the present invention can be utilized in various fields related to cargo delivery within the skin; and in fields related to skin condition improvement.
[0159]
[0160] Foregoing, specific parts of the present invention have been described in detail. It will be apparent to those skilled in the art that such specific descriptions are merely preferred embodiments and do not limit the scope of the invention. Accordingly, the actual scope of the invention is defined by the appended claims and their equivalents.
Claims
1. A peptide represented by the amino acid sequence of Sequence No. 1; A peptide represented by the amino acid sequence of SEQ ID NO. 2; and Nanoliposomes containing cargo.
2. A nanoliposome according to claim 1, wherein one or more peptides selected from the group consisting of the peptide represented by the amino acid sequence of SEQ ID NO. 1 and the peptide represented by the amino acid sequence of SEQ ID NO. 2 are bound to the surface of the nanoliposome.
3. In paragraph 1, the nano liposome A first region formed by an internal hydrophilic region of a multilayer lamellar structure; Multilayer lamellar structure; and Nanoliposome comprising an outer hydrophilic region of a multilayer lamellar structure.
4. A nanoliposome according to claim 3, wherein one or more peptides selected from the group consisting of a peptide represented by the amino acid sequence of SEQ ID NO. 1 and a peptide represented by the amino acid sequence of SEQ ID NO. 2 are bonded to the outer hydrophilic region of the multilayer lamellar structure.
5. A nanoliposome according to paragraph 3, wherein the cargo is included in the first region formed by the internal hydrophilic region of the multilayer lamellar structure, the multilayer lamellar structure, or the external hydrophilic region of the multilayer lamellar structure.
6. The nanoliposome according to claim 1, wherein the cargo is hyaluronic acid having a molecular weight of 3,000 to 3,000,000 Da.
7. In claim 1, the nano liposome is a nano liposome having a size of 1 to 500 nm.
8. In paragraph 1, the nano liposome is a nano liposome for transdermal administration.
9. A cosmetic composition for improving skin condition comprising a nano liposome according to any one of claims 1 to 8.
10. A cosmetic composition for improving skin condition according to claim 9, wherein the skin condition improvement is skin moisturization, skin regeneration, improvement of skin wrinkles, enhancement of skin elasticity, alleviation of skin irritation, or soothing of the skin.
11. A cargo delivery composition comprising a nanoliposome according to any one of claims 1 to 8.
12. A cargo delivery composition according to claim 11, wherein the cargo is a hydrophilic cargo or a hydrophobic cargo. 13.(a) A step of preparing a first mixture in which the peptides are dispersed by mixing a phospholipid, the peptide of SEQ ID NO. 1, and the peptide of SEQ ID NO. 2; (b) a step of preparing a second mixture by mixing the first mixture of step (a) and a water-soluble cargo; and (c) a step of applying pressure to the second mixture of step (b) to nanoscale it; a method for manufacturing nano liposomes comprising.
14. A peptide represented by the amino acid sequence of Sequence No. 1; A peptide represented by the amino acid sequence of SEQ ID NO. 2; and A method for improving skin condition comprising the step of administering a composition containing nanoliposomes containing Cargo to an individual in need thereof.
15. A peptide represented by the amino acid sequence of Sequence No. 1; A peptide represented by the amino acid sequence of SEQ ID NO. 2; and A method for delivering cargo comprising the step of administering a composition containing nanoliposomes containing cargo to an individual in need thereof.
